A detailed history of State Board Of Administration Of Florida Retirement System transactions in United Therapeutics Corp stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 41,419 shares of UTHR stock, worth $15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
41,419
Previous 41,419 -0.0%
Holding current value
$15 Million
Previous $13.2 Million 12.49%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$228.26 - $319.04 $1.55 Million - $2.16 Million
-6,778 Reduced 14.06%
41,419 $13.2 Million
Q1 2024

May 08, 2024

BUY
$210.76 - $249.51 $252,912 - $299,412
1,200 Added 2.55%
48,197 $11.1 Million
Q4 2023

Feb 09, 2024

SELL
$214.88 - $256.94 $1.26 Million - $1.5 Million
-5,857 Reduced 11.08%
46,997 $10.3 Million
Q3 2023

Nov 08, 2023

BUY
$211.82 - $248.24 $1.38 Million - $1.62 Million
6,514 Added 14.06%
52,854 $11.9 Million
Q2 2023

Aug 11, 2023

SELL
$205.19 - $232.99 $381,037 - $432,662
-1,857 Reduced 3.85%
46,340 $10.2 Million
Q1 2023

Jun 14, 2023

BUY
$212.99 - $276.17 $264,107 - $342,450
1,240 Added 2.64%
48,197 $10.8 Million
Q1 2023

May 11, 2023

BUY
$212.99 - $276.17 $264,107 - $342,450
1,240 Added 2.64%
48,197 $10.8 Million
Q4 2022

Jun 14, 2023

SELL
$205.95 - $280.43 $255,378 - $347,733
-1,240 Reduced 2.57%
46,957 $13.1 Million
Q4 2022

Feb 07, 2023

SELL
$205.95 - $280.43 $105,034 - $143,019
-510 Reduced 1.07%
46,957 $13.1 Million
Q3 2022

Nov 08, 2022

SELL
$203.3 - $244.17 $239,894 - $288,120
-1,180 Reduced 2.43%
47,467 $9.94 Million
Q2 2022

Aug 05, 2022

SELL
$174.81 - $241.14 $305,742 - $421,753
-1,749 Reduced 3.47%
48,647 $11.5 Million
Q1 2022

May 06, 2022

SELL
$166.16 - $213.96 $209,361 - $269,589
-1,260 Reduced 2.44%
50,396 $9.04 Million
Q4 2021

Feb 08, 2022

SELL
$184.32 - $216.08 $1.03 Million - $1.21 Million
-5,595 Reduced 9.77%
51,656 $11.2 Million
Q3 2021

Nov 08, 2021

SELL
$179.86 - $214.88 $29,497 - $35,240
-164 Reduced 0.29%
57,251 $10.6 Million
Q2 2021

Aug 10, 2021

BUY
$170.47 - $211.93 $389,864 - $484,683
2,287 Added 4.15%
57,415 $10.3 Million
Q1 2021

May 10, 2021

SELL
$153.94 - $174.85 $1.28 Million - $1.45 Million
-8,302 Reduced 13.09%
55,128 $9.22 Million
Q4 2020

Feb 08, 2021

SELL
$101.87 - $151.79 $716,757 - $1.07 Million
-7,036 Reduced 9.98%
63,430 $9.63 Million
Q3 2020

Nov 09, 2020

BUY
$99.9 - $121.13 $1.02 Million - $1.24 Million
10,235 Added 16.99%
70,466 $7.12 Million
Q2 2020

Aug 07, 2020

BUY
$92.74 - $125.82 $206,624 - $280,326
2,228 Added 3.84%
60,231 $7.29 Million
Q1 2020

May 05, 2020

BUY
$79.39 - $115.35 $117,179 - $170,256
1,476 Added 2.61%
58,003 $5.5 Million
Q4 2019

Feb 03, 2020

BUY
$78.31 - $95.34 $8,535 - $10,392
109 Added 0.19%
56,527 $4.98 Million
Q3 2019

Nov 07, 2019

BUY
$74.85 - $85.99 $61,376 - $70,511
820 Added 1.47%
56,418 $4.5 Million
Q2 2019

Aug 05, 2019

SELL
$76.06 - $120.81 $1.11 Million - $1.77 Million
-14,623 Reduced 20.82%
55,598 $4.34 Million
Q1 2019

May 03, 2019

BUY
$107.15 - $126.84 $544,750 - $644,854
5,084 Added 7.81%
70,221 $8.24 Million
Q4 2018

Feb 01, 2019

SELL
$101.4 - $128.73 $641,050 - $813,831
-6,322 Reduced 8.85%
65,137 $7.09 Million
Q3 2018

Oct 31, 2018

SELL
$113.81 - $129.46 $291,695 - $331,805
-2,563 Reduced 3.46%
71,459 $9.14 Million
Q2 2018

Aug 06, 2018

BUY
$101.14 - $118.31 $910,967 - $1.07 Million
9,007 Added 13.85%
74,022 $8.38 Million
Q1 2018

May 04, 2018

SELL
$107.21 - $151.94 $10,077 - $14,282
-94 Reduced 0.14%
65,015 $7.31 Million
Q4 2017

Feb 01, 2018

SELL
$118.58 - $151.28 $1.46 Million - $1.87 Million
-12,329 Reduced 15.92%
65,109 $9.63 Million
Q3 2017

Oct 31, 2017

BUY
$114.6 - $136.81 $8.87 Million - $10.6 Million
77,438
77,438 $9.08 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.